Additive effects of hyperlipidemia and rejection on development of graft coronary vasculopathy following cardiac transplantation

被引:0
|
作者
El-Hamamsy, I [1 ]
Perrault, LP [1 ]
机构
[1] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:373 / 373
页数:1
相关论文
共 50 条
  • [31] Correlation of Immunological Markers With Graft Vasculopathy Development in Heart Transplantation
    Roldan, C.
    Mirabet, S.
    Brossa, V.
    Molto, E.
    Lopez, L.
    Alvaro, Y.
    Sole, E.
    Padro, J. M.
    Gelpi, C.
    Roig, E.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2653 - 2656
  • [32] Correlation of Immunological Markers with Graft Vasculopathy Development in Heart Transplantation
    Gelpi, C.
    Roldan, C.
    Mirabet, S.
    Brossa, V.
    Lopez, L.
    Mendez, A.
    Pedro, J. M.
    Roig, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S167 - S167
  • [33] Combined Heart and Kidney Transplantation Provides an Excellent Survival and Decreases Risk of Cardiac Cellular Rejection and Coronary Allograft Vasculopathy
    Raichlin, E.
    Kushwaha, S. S.
    Daly, R. C.
    Kremers, W. K.
    Frantz, R. P.
    Clavell, A. L.
    Rodeheffer, R. J.
    Larson, T. S.
    Stegall, M. D.
    McGregor, C.
    Pereira, N. L.
    Edwards, B. S.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (05) : 1871 - 1876
  • [34] Prevalence of Microvascular Cardiac Allograft Vasculopathy Following Heart Transplantation
    Clerkin, K. J.
    Lee, J. H.
    Restaino, S. W.
    Latif, F.
    Yuzefpolskaya, M.
    Colombo, P. C.
    Farr, M. A.
    Bokhari, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S411 - S412
  • [35] Erythropoietin (Epo) and Biomarkers of Endothelial Repair in the Development of Allograft Vasculopathy Following Pediatric Cardiac Transplantation
    Stack, Maria P.
    Seifert, Michael
    Datta, Dipak
    Zurakowski, David
    Messere, Jane
    Blume, Betsy
    Briscoe, David M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 56 - 56
  • [36] Arginine polymers inhibit graft coronary artery disease following cardiac transplantation.
    Kown, MH
    van der Steenhoven, T
    Jahncke, CL
    Hoyt, GE
    Rothbard, JB
    Robbins, R
    TRANSPLANTATION, 2000, 69 (08) : S300 - S300
  • [37] Myocardial apoptosis in a heterotopic murine heart transplantation model of chronic rejection and graft vasculopathy
    White, WL
    Zhang, YL
    Shelby, J
    Trautman, MS
    Perkins, SL
    Hammond, EH
    Shaddy, RE
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1997, 16 (02): : 250 - 255
  • [38] Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation
    Bergmark, Brian A.
    Zelniker, Thomas A.
    Kim, Miae
    Mehra, Mandeep R.
    Stewart, Garrick C.
    Page, Deborah S.
    Woodcome, Erica L.
    Givertz, Michael M.
    CLINICAL TRANSPLANTATION, 2021, 35 (10)
  • [39] Cardiac allograft rejection is an independent risk factor for graft coronary artery disease late after transplantation
    BrunnerLaRocca, HP
    Kiowski, W
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 99153 - 99153
  • [40] HLA Matching in Cardiac Transplantation - Impact on Cardiac Allograft Vasculopathy, Rejection and Donor Specific Antibodies
    Holzhauser, Luise
    Misra, Maneesh
    Miller, Tamari
    Kalantari, Sara
    Smith, Bryan
    Ann Nguyen
    Chung, Bow
    Sarswat, Nitasha
    Kim, Gene
    Marino, Susana
    Grinstein, Jonathan
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S157 - S157